Application Information

Application Number : 2026/000786

Application Date : 18-09-2020

Application Type : EPC Fasikül

Grant Number : 2026-GE-38413

Grant Date : 20-01-2026

Registration Number : 2026 000786

Registration Date : 2026-02-23

Protection Type : Patent

European Patent Publication Number (B1) : EP4031110B1

European Patent Application Number : EP20781719.8

Applicants

Person No	Name	Address
7983065	BRISTOL-MYERS SQUIBB COMPANY	ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NJ 08543 A.B.D.

Inventors

Person No	Name	Address
7983053	Sherif Ibrahim Farag BADAWY	C/O BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NEW JERSEY 08543 A.B.D.
7983054	Jonathan R BROWN	C/O BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED BLDG. 3, REEDS LANE MORETON MERSEYSIDE CH46 1QW BİRLEŞİK KRALLIK
7983055	Candice Y CHOI	C/O BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NEW JERSEY 08543 A.B.D.
7983056	Christoph GESENBERG	C/O BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NEW JERSEY 08543 A.B.D.
7983057	Vivienne GRAY	C/O BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED BLDG. 3, REEDS LANE MORETON MERSEYSIDE CH46 1QW BİRLEŞİK KRALLIK
7983064	Ian YATES	C/O SERAN BIOSCIENCE, INC. 63040 LOWER MEADOW DRIVE BEND, OREGON 97701 A.B.D.
7983059	Umesh KESTUR	C/O BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NEW JERSEY 08543 A.B.D.
7983060	Balvinder S VIG	C/O BRISTOL-MYERS SQUIBB COMPANY 38 JACKSON ROAD DEVENS, MASSACHUSETTS 01434 A.B.D.
7983061	S Xiaotian YIN	C/O BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NEW JERSEY 08543 A.B.D.
7983062	Christopher A ZORDAN	C/O BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NEW JERSEY 08543 A.B.D.
7983063	Corey BLOOM	19379 BLUE LAKE LOOP BEND, OREGON 97702 A.B.D.
7983058	John Wynne JONES	C/O BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED BLDG. 3, REEDS LANE MORETON MERSEYSIDE CH46 1QW BİRLEŞİK KRALLIK

Invention Information

Name Of Invention	TYK2 İNHİBİTÖRLERİNE YÖNELİK DOZAJ FORMLARI
Summary Of Invention	İltihaplı bağırsak hastalığı (IBD) ve sedef hastalığı gibi otoimmün ve otoinflamatuar hastalıkların tedavisi için, katı amorf 6-(siklopropanamido)-4-((2-metoksi-3-(1-metil-1H-1,2,4-triazol-3-il)fenil)amino)-N-(metil-d3)piridazin-3-karboksamid (Formül (I); BMS-986165)'in katı bir polimer matris içinde dağılımını (örneğin, spreyle kurutulmuş dağılım) içeren stabil ve biyoyararlanılabilir formülasyonlar ve dozaj formları sağlanır.

Attorney Information

Name	TOLGA ÇAYLAK DIŞ PATENT MARKA TESCİL ve DANIŞMANLIK HİZ. LTD. ŞTİ.
Address	GİRNE MAH. ELİFLİ SOK. NO:27 BAY PLAZA KAT:5-6-7 MALTEPE/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
18-09-2019	US 201962902218P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation	Document
	06-02-2026	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
19-01-2026		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
23-02-2026	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)